Net profit of Lincoln Pharmaceuticals rose 29.75% to Rs 28.04 crore in the quarter ended December 2023 as against Rs 21.61 crore during the previous quarter ended December 2022. Sales rose 9.48% to Rs 146.45 crore in the quarter ended December 2023 as against Rs 133.77 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales146.45133.77 9 OPM %20.2520.00 - PBDT40.5232.78 24 PBT37.7130.51 24 NP28.0421.61 30 Powered by Capital Market - Live News

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News

Net profit of Lincoln Pharmaceuticals rose 16.62% to Rs 27.65 crore in the quarter ended September 2023 as against Rs 23.71 crore during the previous quarter ended September 2022. Sales rose 10.94% to Rs 155.99 crore in the quarter ended September 2023 as against Rs 140.61 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales155.99140.61 11 OPM %19.9720.55 - PBDT39.4534.48 14 PBT36.8732.06 15 NP27.6523.71 17 Powered by Capital Market - Live News

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 November 2023.Powered by Capital Market - Live News

Lincoln Pharmaceuticals announced that the 29th Annual General Meeting (AGM) of the company will be held on 30 September 2023.Powered by Capital Market - Live News